Mucormycosis as a complication of COVID-19 coronavirus infection: eye symptoms
COVID-19 causes an immunosuppressive condition and increases the risk of secondary infections, including fungal diseases such as mucormycosis (MM), so doctors should be aware of the possibility of MM development in COVID-19 patients. Since no specific complaints or clinical symptoms exist and the di...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Real Time Ltd
2024-07-01
|
| Series: | Российский офтальмологический журнал |
| Subjects: | |
| Online Access: | https://roj.igb.ru/jour/article/view/1499 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850047626896998400 |
|---|---|
| author | A. E. Babushkin L. I. Gilemzianova I. P. Ponomarev |
| author_facet | A. E. Babushkin L. I. Gilemzianova I. P. Ponomarev |
| author_sort | A. E. Babushkin |
| collection | DOAJ |
| description | COVID-19 causes an immunosuppressive condition and increases the risk of secondary infections, including fungal diseases such as mucormycosis (MM), so doctors should be aware of the possibility of MM development in COVID-19 patients. Since no specific complaints or clinical symptoms exist and the disease is rare, especially in developed countries with a moderate climate, it is often impossible to diagnose MM at the initial examination. Therefore, the detection of the pathogen (mycelium zygomycetes) plays a key role in the diagnosis. Over 70 % of MM patients experience eye damages. According to the literature, the most common manifestations thereof are blepharoptosis, ophthalmoplegia, exophthalmos, injection and conjunctival chemosis. Quite often, the patients have eye pains, orbital cellulitis or phlegmon of the orbit, accompanied by a decrease in vision. For the effective treatment of this severe infectious COVID-19 complication, which takes the form of deep and aggressive mycosis, an interdisciplinary approach is necessary. The complex treatment should make use of antimycotic agents and symptomatic therapy, and, essentially, surgical rehabilitation of infection foci by removing the affected necrotic tissues. The prognosis is always very serious. |
| format | Article |
| id | doaj-art-1d7678bd1d924f3aaba638e9f68b85ac |
| institution | DOAJ |
| issn | 2072-0076 2587-5760 |
| language | Russian |
| publishDate | 2024-07-01 |
| publisher | Real Time Ltd |
| record_format | Article |
| series | Российский офтальмологический журнал |
| spelling | doaj-art-1d7678bd1d924f3aaba638e9f68b85ac2025-08-20T02:54:11ZrusReal Time LtdРоссийский офтальмологический журнал2072-00762587-57602024-07-0117211612010.21516/2072-0076-2024-17-2-116-120696Mucormycosis as a complication of COVID-19 coronavirus infection: eye symptomsA. E. Babushkin0L. I. Gilemzianova1I. P. Ponomarev2Ufa Eye Research Institute, Bashkir Medical UniversityUfa Eye Research Institute, Bashkir Medical UniversityUfa Eye Research Institute, Bashkir Medical UniversityCOVID-19 causes an immunosuppressive condition and increases the risk of secondary infections, including fungal diseases such as mucormycosis (MM), so doctors should be aware of the possibility of MM development in COVID-19 patients. Since no specific complaints or clinical symptoms exist and the disease is rare, especially in developed countries with a moderate climate, it is often impossible to diagnose MM at the initial examination. Therefore, the detection of the pathogen (mycelium zygomycetes) plays a key role in the diagnosis. Over 70 % of MM patients experience eye damages. According to the literature, the most common manifestations thereof are blepharoptosis, ophthalmoplegia, exophthalmos, injection and conjunctival chemosis. Quite often, the patients have eye pains, orbital cellulitis or phlegmon of the orbit, accompanied by a decrease in vision. For the effective treatment of this severe infectious COVID-19 complication, which takes the form of deep and aggressive mycosis, an interdisciplinary approach is necessary. The complex treatment should make use of antimycotic agents and symptomatic therapy, and, essentially, surgical rehabilitation of infection foci by removing the affected necrotic tissues. The prognosis is always very serious.https://roj.igb.ru/jour/article/view/1499coronavirus infectioncovid-19complicationimmunosuppressive staterisk of secondary infectionsmucormycosiseye damage |
| spellingShingle | A. E. Babushkin L. I. Gilemzianova I. P. Ponomarev Mucormycosis as a complication of COVID-19 coronavirus infection: eye symptoms Российский офтальмологический журнал coronavirus infection covid-19 complication immunosuppressive state risk of secondary infections mucormycosis eye damage |
| title | Mucormycosis as a complication of COVID-19 coronavirus infection: eye symptoms |
| title_full | Mucormycosis as a complication of COVID-19 coronavirus infection: eye symptoms |
| title_fullStr | Mucormycosis as a complication of COVID-19 coronavirus infection: eye symptoms |
| title_full_unstemmed | Mucormycosis as a complication of COVID-19 coronavirus infection: eye symptoms |
| title_short | Mucormycosis as a complication of COVID-19 coronavirus infection: eye symptoms |
| title_sort | mucormycosis as a complication of covid 19 coronavirus infection eye symptoms |
| topic | coronavirus infection covid-19 complication immunosuppressive state risk of secondary infections mucormycosis eye damage |
| url | https://roj.igb.ru/jour/article/view/1499 |
| work_keys_str_mv | AT aebabushkin mucormycosisasacomplicationofcovid19coronavirusinfectioneyesymptoms AT ligilemzianova mucormycosisasacomplicationofcovid19coronavirusinfectioneyesymptoms AT ipponomarev mucormycosisasacomplicationofcovid19coronavirusinfectioneyesymptoms |